CodeSystem Comparison between http://terminology.hl7.org/CodeSystem/v2-0252 vs http://terminology.hl7.org/CodeSystem/v2-0252

Messages

ErrorCodeSystem.versionValues for version differ: '3.0.0' vs '2.0.0'
WarningCodeSystem.property.where(code='status').uriChanged value for uri: 'http://hl7.org/fhir/concept-properties#status' vs 'http://terminology.hl7.org/CodeSystem/utg-concept-properties#status'
WarningCodeSystem.property.where(code='status').descriptionChanged value for description: 'A code that indicates the status of the concept' vs 'Status of the concept'

Metadata

NameValueComments
.caseSensitivetrue
    .compositionalfalse
      .contentcomplete
        .copyrightThis material derives from the HL7 Terminology (THO). THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license.html
          .date2019-12-01
            .descriptionHL7-defined code system of concepts used to record event observations regarding what may have caused a product related event. Used in HL7 Version 2.x messaging in the PCR segment.
              .experimentalfalse
                .hierarchyMeaningis-a
                  .jurisdiction
                    .nameCausalityObservations
                      .publisherHealth Level Seven International
                        .purposeUnderlying Master Code System for V2 table 0252 (Causality Observations)
                          .statusactive
                            .titlecausalityObservations
                              .urlhttp://terminology.hl7.org/CodeSystem/v2-0252
                                .version3.0.02.0.0
                                • Values Differ
                                .versionNeededfalse

                                  Concepts

                                  CodeDisplaystatusv2-table-deprecatedstatusv2-table-deprecateddeprecatedComments
                                  .AWAbatement of event after product withdrawnactiveAactiveA
                                    .BEEvent recurred after product reintroducedactiveAactiveA
                                      .LILiterature reports association of product with eventactiveAactiveA
                                        .INEvent occurred after product introducedactiveAactiveA
                                          .EXAlternative explanations for the event availableactiveAactiveA
                                            .PLEffect observed when patient receives placeboactiveAactiveA
                                              .TCToxic levels of product documented in blood or body fluidsactiveAactiveA
                                                .DRDose response observedactiveAactiveA
                                                  .SESimilar events in past for this patientactiveAactiveA
                                                    .OEOccurrence of event was confirmed by objective evidenceactiveAactiveA
                                                      .OTOtheractiveAactiveA